Aurora Daljit Singh 4

What Happened

• Aurora Daljit Singh, Chief Operating and Development Officer of Neumora Therapeutics (NMRA), sold 6,165 shares on 2026-02-17 at $3.56 per share, generating approximately $21,917. The filing notes the sale was to satisfy tax withholding obligations related to the vesting of restricted stock units.

Key Details

• Transaction date & price: 2026-02-17, 6,165 shares @ $3.56 each (total ≈ $21,917).
• Transaction type: Sale (S); footnote F1 specifies sale to satisfy tax withholding for RSU vesting.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Filing date and timeliness: Form 4 filed 2026-02-19, within the standard 2-business-day reporting window (timely).
• No 10b5-1 plan or other arrangements were indicated in the provided notes.

Context

• Sales to cover tax withholding on vested RSUs are routine and commonly do not signal an insider’s change in conviction about the company’s prospects. For retail investors, such transactions are typically administrative rather than investment-driven.